Увійти

Готові списки джерел за темами / Systemic experience / Статті в журналах

Статті в журналах з теми "Systemic experience"

Щоб переглянути інші типи публікацій з цієї теми, перейдіть за посиланням: Systemic experience.

Автор: Grafiati

Опубліковано: 13 квітня 2024

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Systemic experience".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.

1

Hildebrand, Judy, and Desa Markovic. "Systemic Therapists' Experience of Powerlessness." Australian and New Zealand Journal of Family Therapy 28, no. 04 (December 2007): 191–99. http://dx.doi.org/10.1375/anft.28.4.191.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Keashly, Loraleigh. "Interpersonal and Systemic Aspects of Emotional Abuse at Work: The Target’s Perspective." Violence and Victims 16, no. 3 (January 2001): 233–68. http://dx.doi.org/10.1891/0886-6708.16.3.233.

Повний текст джерела

Анотація:

The most frequent form of workplace aggression is not physical, it is emotional and psychological in nature. Known by many names, emotional abuse at work is rapidly becoming recognized as pervasive and costly both in individual and organizational terms. Most of the research to date on emotional abuse at work has utilized survey and other quantitative methodologies in an effort to document the presence, prevalence, and impact of these behaviors. However, these methodologies are based on researchers’ definitions and theories of what constitutes emotional abuse rather than on the meaning given to these experiences by the targets of these behaviors. A thorough understanding of this phenomenon requires a scholarly appreciation of the target’s experience. Taking “feeling abused” as the criterion variable, this study examined target’s experiences based on interviews with people who self-identifed as having experienced difficulties with a boss, coworker, or subordinate. The interpersonal aspects of emotional abuse focused on the nature of behaviors exhibited and the respondents’ labeling of their experience. Consistent with elements of researchers’ definitions, behaviors were defined as abusive when they were repetitive, resulted in injury or harm to target, and were experienced as a lack of recognition of the individual’s integrity. Judgments of violation of standards of conduct and unsolicited nature of the behaviors were also related to respondents’ experiences. Relative power differential was also an important element. However, contrary to researchers’ definitions, actor intent was not central in defining the experience as abusive. The systemic aspect of emotional abuse was illustrated in the nature of organizational responding to concerns raised by respondents. These responses were of critical importance in respondents’ labeling of their experiences as abusive. The focus on the meaning of the behaviors for the respondents provides an enriched picture of key definitional elements. Implications of the findings for future research are discussed.

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Strizhakov A, Strizhakov A N., Ignatko I V. Ignatko I, Bogomazova I. M. Bogomazova, Belousova V S. Belousova V, Timokhina E V. Timokhina E, Afanasyeva N V. Afanasyeva N, and Khramova L S. Khramova L. "Successful experience with systemic thrombolysis during pregnancy." Akusherstvo i ginekologiia 9_2021 (September 23, 2021): 222–26. http://dx.doi.org/10.18565/aig.2021.9.222-226.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Bahrami, Simin, Steven S. Raman, Steven Sauk, Saleh Salehmoghaddam, Juan Pablo Villablanca, J. Paul Finn, and David S. K. Lu. "Ten-Year Experience With Nephrogenic Systemic Fibrosis." Journal of Computer Assisted Tomography 33, no. 6 (November 2009): 819–23. http://dx.doi.org/10.1097/rct.0b013e31819d68ed.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Galluccio, F., U. A. Walker, S. Nihtyanova, P. Moinzadeh, N. Hunzelmann, T. Krieg, V. Steen, et al. "Registries in systemic sclerosis: a worldwide experience." Rheumatology 50, no. 1 (December 8, 2010): 60–68. http://dx.doi.org/10.1093/rheumatology/keq355.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Sridhara, S., J. H. Butterfield, and C. R. Weiler. "Systemic Mastocytosis: Mayo clinic experience since 2000." Journal of Allergy and Clinical Immunology 127, no. 2 (February 2011): AB251. http://dx.doi.org/10.1016/j.jaci.2010.12.1000.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Viviani, Maria Anna, Anna Maria Tortorano, Antonio Pagano, Gian Marco Vigevani, Guido Gubertini, Silvia Cristina, Maria Luisa Assaisso, et al. "European experience with itraconazole in systemic mycoses." Journal of the American Academy of Dermatology 23, no. 3 (September 1990): 587–93. http://dx.doi.org/10.1016/0190-9622(90)70260-o.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Saketkoo, Lesley Ann, Jessica K. Gordon, Kim Fligelstone, Anne Mawdsley, Humza A. Chaudhry, Antonia Valenzuela, Angela Christensen, et al. "Patient Experience of Systemic Sclerosis–Related Calcinosis." Rheumatic Disease Clinics of North America 49, no. 2 (May 2023): 463–81. http://dx.doi.org/10.1016/j.rdc.2023.01.017.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Soleau, Scott W., Richard Schmidt, Steve Stevens, Anne Osborn, and Joel D. MacDonald. "Extensive Experience with Dural Sinus Thrombosis." Neurosurgery 52, no. 3 (March 1, 2003): 534–44. http://dx.doi.org/10.1227/01.neu.0000047815.21786.c1.

Повний текст джерела

Анотація:

Abstract OBJECTIVE Dural sinus thrombosis (DST) is an uncommon cause of stroke. The safest and most effective therapy for DST has not been conclusively identified. METHODS A retrospective chart review of data for 31 patients who were treated for DST at our institution between 1992 and 2001 was performed. Four treatment strategies were identified, i.e., 1) medical observation only, 2) systemic anticoagulation (AC) therapy with heparin, 3) endovascular chemical thrombolysis with urokinase or tissue plasminogen activator and concurrent systemic AC therapy, and 4) mechanical endovascular clot thrombolysis with concurrent systemic AC therapy. Complications and clinical outcomes were assessed for each group. RESULTS Patients treated solely with medical observation fared the worst; four of five patients experienced intracranial hemorrhagic complications, and only two of five exhibited clinical improvement. Patients who received systemic AC therapy experienced no hemorrhagic complications, even when pretreatment hemorrhage was present; 75% (six of eight patients) exhibited improvement with AC therapy alone. Chemical thrombolysis was very effective in restoring sinus patency (90% of patients); however, 30% of patients (3 of 10 patients) experienced hemorrhagic complications. Sixty percent of patients (6 of 10 patients) who underwent chemical thrombolysis exhibited clinical improvement. Patients who underwent mechanical thrombectomies demonstrated a low hemorrhagic complication rate, and most (88%) made good recoveries. CONCLUSION Therapy directed at the underlying clot in DST must begin without delay. Our results suggest that supportive medical management of DST, without therapy directed at the clot or clotting process, is not effective. Systemic AC therapy, even in the presence of intracerebral hemorrhage, seems to be safe. Heparin can be safely titrated to yield partial thromboplastin times of 60 to 70 seconds. Chemical clot thrombolysis is efficacious in opening occluded sinuses but may cause intracranial hemorrhage. We currently recommend either systemic AC therapy or systemic AC therapy in conjunction with mechanical clot thrombectomy as a safe effective treatment for DST.

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Handlovsky, Ingrid, Vicky Bungay, John Oliffe, and Joy Johnson. "Developing Resilience: Gay Men’s Response to Systemic Discrimination." American Journal of Men's Health 12, no. 5 (April 23, 2018): 1473–85. http://dx.doi.org/10.1177/1557988318768607.

Повний текст джерела

Анотація:

Gay men experience marked health disparities compared to heterosexual men, associated with profound discrimination. Resilience as a concept has received growing attention to increase understanding about how gay men promote and protect their health in the presence of adversity. Missing in this literature are the perspectives and experiences of gay men over 40 years. This investigation, drawing on grounded theory methods, examined how gay men over 40 years of age develop resilience over the course of their lives to promote and protect their health. In-depth interviews were undertaken with 25 men ranging between 40 and 76 years of age who experienced an array of health concerns including depression, anxiety, suicidality, and HIV. Men actively resist discrimination via three interrelated protective processes that dynamically influence the development of resilience over their life course: (a) building and sustaining networks, (b) addressing mental health, and (c) advocating for respectful care encounters. Initiatives to promote and protect the health of gay men must be rooted in the recognition of the systemic role of discrimination, while supporting men’s resilience in actively resisting discrimination.

Стилі APA, Harvard, Vancouver, ISO та ін.

11

Duguay, Cynthia, Frances Gallagher, and Martin Fortin. "The Experience of Adults with Multimorbidity: A Qualitative Study." Journal of Comorbidity 4, no. 1 (January 2014): 11–21. http://dx.doi.org/10.15256/joc.2014.4.31.

Повний текст джерела

Анотація:

Background Findings from several countries indicate that the prevalence of multimorbidity is very high among clients of primary healthcare. A deeper understanding of patients’ experiences from their own perspective can greatly enrich any intervention to help them live as well as possible with multimorbidity. Objective To describe the fundamental structure of adults’ experience with multimorbidity. Design A phenomenological study was undertaken to describe the experiences of 11 adults with multimorbidity. These adults participated in two semi-structured interviews, the content of which was rigorously analyzed. Results At the core of the study participants’ multimorbidity experience are the impression of aging prematurely, difficulties with self-care management, and issues with access to the healthcare system, which contribute to the problem's complexity. Despite these issues, participants with multimorbidity report attempting to take control of their situation and adjusting to daily living. Conclusions The description of this experience, through the systemic vision of participants, provides a better understanding of the realities experienced by people with multimorbidity.

Стилі APA, Harvard, Vancouver, ISO та ін.

12

Haghighi, AfshinBorhani, and ShahabGhasem Haza. "Neuropsychiatric manifestations of systemic lupus erythematosus: Iranian experience." Annals of Indian Academy of Neurology 13, no. 2 (2010): 108. http://dx.doi.org/10.4103/0972-2327.64633.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

13

Boogaerts, Marc, and Johan Maertens. "Clinical Experience with Itraconazole in Systemic Fungal Infections." Drugs 61, Supplement 1 (2001): 39–47. http://dx.doi.org/10.2165/00003495-200161001-00004.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

14

Pannelier, C., A. Vienet, and E. Chwetzoff. "Itraconazole in Systemic Aspergillosis: Experience in 22 Cases." Chemotherapy 38, no. 1 (1992): 54. http://dx.doi.org/10.1159/000239074.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

15

Lee, Han Chu. "Systemic Chemotherapy of Hepatocellular Carcinoma – Korean Experience." Oncology 75, no. 1 (2008): 114–18. http://dx.doi.org/10.1159/000173432.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

16

Kostić Dedić, S., V. Cvijanović, D. Jovanović, T. Smiljković, V. Nikolić, A. Gavrilović Ðokić, and J. Malović. "Sensory-motor polyneuropathy in systemic amyloidosis - our experience." Clinical Neurophysiology 126, no. 9 (September 2015): e182. http://dx.doi.org/10.1016/j.clinph.2015.04.040.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

17

Lanciano, E., E. Praino, C. Rotondo, M. Covelli, F. Iannone, and G. Lapadula. "AB0494 Systemic sclerosis and cancer risk: our experience." Annals of the Rheumatic Diseases 72, Suppl 3 (June 2013): A939.3—A940. http://dx.doi.org/10.1136/annrheumdis-2013-eular.2816.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

18

Zaki, I. "Systemic therapy of atopic dermatitis -- experience in children." Journal of the European Academy of Dermatology and Venereology 5, no. 1 (October 1995): S181—S182. http://dx.doi.org/10.1016/0926-9959(95)96521-9.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

19

Yosr, Boussoukaya, Thabet Maissa, Kouki Syrine, Elkarouss Hana, Guiga Ahmed, Ben Yahia Wissal, Amara Amel, Atig Amira, and Ghannouchi Neirouz. "Systemic Lupus Erythematosus and Skin Damage: Patient’s Experience." Journal of Innovations in Medical Research 2, no. 7 (July 2023): 32–34. http://dx.doi.org/10.56397/jimr/2023.07.05.

Повний текст джерела

Анотація:

Systemic lupus erythematosus (SLE) is a non-organ-specific autoimmune disease that affects young patients and women in particular. We describe a Cross-sectional study conducted in the internal medicine department of Farhat Hached University Hospital in Sousse, Tunisia. We interviewed 12 patients with SLE about what they know about SLE, their skin symptoms and the measures they take on a daily basis to protect themselves. The DLQI questionnaire was used to evaluate their dermatological quality of life using.

Стилі APA, Harvard, Vancouver, ISO та ін.

20

Patel, Kalpesh, Abhishek Gugliani, and Dhwani Mehta. "Managing Rhino-cerebral Mucormycosis: Institutional Experience." Bengal Journal of Otolaryngology and Head Neck Surgery 27, no. 3 (December 29, 2019): 240–42. http://dx.doi.org/10.47210/bjohns.2019.v27i3.15.

Повний текст джерела

Анотація:

Introduction Rhinocerebral mucormycosis is a rapidly progressive life threatening opportunistic fungal disease and usually occurs in individuals with weakened immune system. It is caused by filamentous fungi of Mucorales from class Mucormycotina. After nasal inoculation, it usually spreads to orbit and brain. The common presenting complaints are purulent sinusitis, facial swelling, headache, complaints of vision or palatal ulceration. Despite the many recent advances in the diagnosis and management of mucormycosis, it still carries a high mortality rate. Materials and methods Here we present our experience in managing 30 such cases of mucormycosis that presented to our department between June 2016 to June 2018. Results All these patients were started on systemic antifungals with or without surgical debridement. The patients were followed up with repeated nasal endoscopies and imaging studies. Conclusion Successful treatment of mucormycosis consists of aggressive repeated surgical debridement of necrotic tissue, systemic antifungal therapy and immediate control of underlying systemic diseases. Since there are no clear-cut guidelines, the treatment needs to be individualized on a case to case basis.

Стилі APA, Harvard, Vancouver, ISO та ін.

21

Nicoloro-SantaBarbara, Jennifer, Fatima Scipione, Marcie Reeder, and Teresa Green. "The Five Dimensions of the Indolent Systemic Mastocytosis Patient Experience – Uncovering the "Real-world” Experience of Patients with Indolent Systemic Mastocytosis." Journal of Allergy and Clinical Immunology 153, no. 2 (February 2024): AB224. http://dx.doi.org/10.1016/j.jaci.2023.11.721.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

22

Camm, Christian Fielder, Abhishek Joshi, Abigail Moore, Hannah C. Sinclair, Mark Westwood, John Pierre Greenwood, Alison Calver, Simon Ray, and Christopher Allen. "Bullying in UK cardiology: a systemic problem requiring systemic solutions." Heart 108, no. 3 (December 6, 2021): 212–18. http://dx.doi.org/10.1136/heartjnl-2021-319882.

Повний текст джерела

Анотація:

ObjectivesBullying of trainee doctors has been shown to be associated with detrimental outcomes for both doctors and patients. However, there is limited evidence regarding the level of bullying of trainees within medical specialties.MethodsAn annual survey of UK cardiology trainees was conducted through the British Junior Cardiologists’ Association between 2017 and 2020 and asked questions about experiencing and witnessing bullying, and exposure to inappropriate language/behaviour in cardiology departments. Fisher’s exact tests and univariable logistic regression models were used to describe associations between trainee characteristics, and reports of bullying and inappropriate language/behaviour.ResultsOf 1358 trainees, bullying was reported by 152 (11%). Women had 55% higher odds of reporting being bullied (OR: 1.55 95% CI (1.08 to 2.21)). Non-UK medical school graduates were substantially more likely to be bullied (European Economic Area (EEA) OR: 2.22 (1.31 to 3.76), non-EEA/UK OR: 3.16 (2.13 to 4.68)) compared with those graduating from UK-based medical schools. Women were more likely than men to report sexist language (14% vs 4%, p<0.001). Non-UK medical school graduates were more likely to experience racist language (UK 1.5%, EEA 6%, other locations 7%, p=0.006). One-third of trainees (33%) reported at least one inappropriate behaviour with 8% reporting being shouted at or targeted with spontaneous anger. Consultants in cardiology (82%) and other specialties (70%) were most commonly implicated by those reporting bullying.DiscussionBullying and inappropriate language are commonly experienced by cardiology trainees and disproportionately affect women and those who attended non-UK medical schools. Consultants both in cardiology and other specialties are the most commonly reported perpetrators.

Стилі APA, Harvard, Vancouver, ISO та ін.

23

Kneebone, Ian. "Stroke: Experience and adjustment." FPOP Bulletin: Psychology of Older People 1, no. 96 (November 2006): 7–8. http://dx.doi.org/10.53841/bpsfpop.2006.1.96.7.

Повний текст джерела

Анотація:

This paper provides a brief overview of a symposium on stroke presented at the 26th PSIGE Annual Conference held at the University of Sussex in July, 2006. The principal conclusion from the discussion, arising from the papers presented, was that psychologists should be taking a broader (more holistic, systemic) approach to post-stroke adjustment.

Стилі APA, Harvard, Vancouver, ISO та ін.

24

Santin, Chiara. "Rewilding systemic practice." Murmurations: Journal of Transformative Systemic Practice 4, no. 1 (December 10, 2021): 13–31. http://dx.doi.org/10.28963/4.1.3.

Повний текст джерела

Анотація:

This paper is written in the context of the current ecological crisis affecting physical and mental health, social, economic, and political contexts, at local and global levels which calls for the disruption of old ways of thinking, living and moving towards the future through collective action. One way of responding as a systemic and family psychotherapist, has been my experience of rewilding my systemic practice with individuals, couples, and families in the UK since taking therapy outdoors. I will offer some examples of ecotherapy as part of my own personal and professional journey in “coming home” through nature, becoming an outdoor designer of therapeutic space and a minimalist wild therapist. I invite us all to re-think and re-create a therapeutic space which, by its very essence, is wild, meaning boundaryless, infinitely spacious and unpredictable. It can open up opportunities for creativity, for using metaphors to explore meanings beyond words. Nature becomes not only the context in which I practice but my co-therapist or even the primary therapist. Together we can enrich the therapeutic process through moments of magic and facilitate change using a wild reflecting team. In my experience of ecotherapy, voices from the wild carry unique messages, for example, birdsong can provide unexpected voices, useful interruptions or disruptions that can enrich the therapeutic process. Such a wild reflecting team can also be a daring metaphor to welcome the unexpected and unfamiliar into our systemic practices and relationships, to include new emerging and marginalised perspectives which may bring us all more in touch with our wildness, lost indigenous ways of relating and shape our futures through collective action.

Стилі APA, Harvard, Vancouver, ISO та ін.

25

Trischler, Jakob, Anita Zehrer, and Jessica Westman. "A designerly way of analyzing the customer experience." Journal of Services Marketing 32, no. 7 (October 8, 2018): 805–19. http://dx.doi.org/10.1108/jsm-04-2017-0138.

Повний текст джерела

Анотація:

Purpose The purpose of this paper is to evaluate the usability of different design methods in understanding the customer experience from a contextual and systemic standpoint. Design/methodology/approach Three design methods (i.e. personas, observations and collaborative service mapping) were applied to analyze customer experiences in two service settings. These methods’ usability was compared across the two settings. Findings Personas, as informed by phenomenological interviews, provide insights into the customer’s broader lifeworld context. These insights assist in connecting with and understanding the customer experience from a dyadic customer-firm perspective. The involvement of the customer in service mapping activities supports the validation of findings and gives access to experience dimensions beyond the immediate service setting. Research limitations/implications The analysis is limited to three design methods and is based on small samples. Future research should systematically review design methods to provide a basis for a more comprehensive evaluation. Practical implications To successfully capture the contextual and systemic nature of the customer experience, managers should apply interpretive approaches and actively involve selected customers as “experts of their experiences”. The study provides guidelines on how design methods can be combined and applied to a more holistic customer experience analysis. Originality/value The paper shows that design methods, when applied in a combined form, can support an analysis that captures both in-depth insights into the customer’s lifeworld and the complexity of value constellations.

Стилі APA, Harvard, Vancouver, ISO та ін.

26

Ozili, Peterson K. "Non-performing loans in European systemic and non-systemic banks." Journal of Financial Economic Policy 12, no. 3 (September 30, 2019): 409–24. http://dx.doi.org/10.1108/jfep-02-2019-0033.

Повний текст джерела

Анотація:

Purpose The distinction between systemic banks (GSIBs) and non-systemic banks (non-GSIBs) is driven by policy reasons. This study aims to examine the behaviour of non-performing loans in European GSIBs and non-GSIBs from 2004 to 2013. Design/methodology/approach The author uses regression methodology to analyse the association between non-performing loans (NPLs) and the state of the economy. Findings The author finds that more profitable banks witness higher NPLs regardless of them being systemic or non-systemic. Secondly, GSIBs have fewer NPLs during economic booms and during periods of increased lending, while non-GSIBs experience higher NPLs during periods of increased lending. The author also observes that European non-GSIBs that exceed regulatory capital requirement also experience higher NPLs. In the post-crisis period, there is a significant and negative relationship between NPLs and the economic cycle for GSIBs in the post-financial crisis period and a significant and positive relationship between NPLs, loan supply and bank profitability for GSIBs in the post-financial crisis period; on the other hand, there is a significant and negative relationship between NPLs and regulatory capital ratios for non-GSIBs in the post-financial crisis period and a significant and positive relationship between NPLs and bank profitability for non-GSIBs in the post-financial crisis period. The findings have implications. Originality/value To the best of the author’s knowledge, the literature on the determinants of NPL has not empirically examined the behaviour of NPLs in European GSIBs and non-GSIBs. This paper examines this issue to provide insights to help policymakers and academics understand the peculiarities of NPLs in Europe.

Стилі APA, Harvard, Vancouver, ISO та ін.

27

Hanauer, Stephen B. "Clinical Experience with Tixocortol Pivalate." Canadian Journal of Gastroenterology 2, no. 4 (1988): 156–58. http://dx.doi.org/10.1155/1988/819089.

Повний текст джерела

Анотація:

Tixocortol pivalate, the 21-thiol derivative of hydrocortisone. is a newly synthesized steroid with topical anti-inflammatory properties but is devoid of systemic glucocorticoid and mineralocorticoid activities and toxicity. The mechanism of action appears to be similar to that of other corticosteroids with regard to steroid binding sites and prostaglandin biosynthesis, however. the disassociation between local and systemic effects is due to a 'first pass' liver metabolism and rapid transformation with in red blood cells. ln both open and controlled studies in patients with acute or recurrent distal colitis, clinical efficacy has been noted at doses of 250 mg to 1000 mg in 100 ml solution without an effect on scrum cortisol levels or blood chemistries. Tixocortol pivalate has consistently shown to be as effective as systemically absorbed steroids for the treatment of distal ulcerative colitis with out the undesirable effects associated with currently available steroid preparations.

Стилі APA, Harvard, Vancouver, ISO та ін.

28

Almeida, Maria do Socorro Teixeira Moreira, Catarina Fernandes Pires, and Joao Vicente Moreira Almeida. "Lung in Systemic Lupus Erythematosus: A Single-Center Experience." OALib 09, no. 09 (2022): 1–9. http://dx.doi.org/10.4236/oalib.1109248.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

29

Coriu, D., S. Badelita, R. Talmaci, C. Dobrea, M. Dogaru, D. Ostroveanu, and M. Crisan. "Bortezomib in systemic AL amyloidosis: a single center experience." Amyloid 18, sup1 (June 2011): 148–50. http://dx.doi.org/10.3109/13506129.2011.574354055.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

30

Sağ, Erdal, Berna Uzunoğlu, Fatma Bal, Hafize Emine Sönmez, Selcan Demir, Yelda Bilginer, and Seza Özen. "Systemic onset juvenile idiopathic arthritis: a single center experience." Turkish Journal of Pediatrics 61, no. 6 (2019): 852. http://dx.doi.org/10.24953/turkjped.2019.06.005.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

31

EMAD, Yasser, Tarek EL-GOHARY, Hisham MUSTAFA, Iman H. BASSYOUNI, and Noha A. AZAB. "Renal angiographic findings in systemic sclerosis: ?the Egyptian experience?" APLAR Journal of Rheumatology 10, no. 1 (April 2007): 43–48. http://dx.doi.org/10.1111/j.1479-8077.2007.00254.x.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

32

Hartmann, A., H. Holdaas, P. Fauchald, K. P. Nordal, K. J. Berg, T. Talseth, T. Leivestad, I. B. Brekke, and A. Flat Mark. "Fifteen years' experience with renal transplantation in systemic amyloidosis." Transplant International 5, no. 1 (January 1992): 15–18. http://dx.doi.org/10.1111/j.1432-2277.1992.tb01716.x.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

33

Pardeo, M., A. Insalaco, C. Bracaglia, R. Nicolai, AE Tozzi, G. Prencipe, and F. De Benedetti. "P01-050 – Anakinra in systemic JIA: single center experience." Pediatric Rheumatology 11, Suppl 1 (2013): A53. http://dx.doi.org/10.1186/1546-0096-11-s1-a53.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

34

Cocco, Annelise M., David Messer, Alexander Brown, Nina Sriram, Jenny Gilchrist, Loma Al-Mansouri, Richard Kefford, et al. "Neoadjuvant systemic therapy for breast cancer: the Westmead experience." ANZ Journal of Surgery 88, no. 6 (September 18, 2017): 640–44. http://dx.doi.org/10.1111/ans.14158.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

35

Nair, Velu, Vivek Vasdev, Abhishek Kumar, Subramanian Shankar, Vivek Nair, and Ajay Sharma. "Stem cell transplant in systemic sclerosis: An Indian experience." International Journal of Rheumatic Diseases 21, no. 4 (February 2, 2018): 859–65. http://dx.doi.org/10.1111/1756-185x.13262.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

36

Ehrmann, Michael, and Paul Schure. "The European Systemic Risk Board – governance and early experience." Journal of Economic Policy Reform 23, no. 3 (December 11, 2019): 290–308. http://dx.doi.org/10.1080/17487870.2019.1683011.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

37

LINDSLEY, CAROL B., and MICHAEL A. LINSHAW. "Systemic Lupus Erythematosus in Childhood: A 10-Year Experience." Pediatric Asthma, Allergy & Immunology 2, no. 4 (January 1988): 279–83. http://dx.doi.org/10.1089/pai.1988.2.279.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

38

CARABELLI, A., G. CROVETTI, M. GUIZZARDI, E. BERTANI, and E. BERTI. "P022 Extracorporeal photochemotherapy and systemic sclerosis: Our preliminary experience." Journal of the European Academy of Dermatology and Venereology 9 (September 1997): S158. http://dx.doi.org/10.1016/s0926-9959(97)89495-0.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

39

Rangel-Guerra, Ricardo A., Héctor R. Martínez, Corando Sáenz, Francisco Bosques-Padilla, and Ingrid Estrada-Bellmann. "Rhinocerebral and systemic mucormycosis. Clinical experience with 36 cases." Journal of the Neurological Sciences 143, no. 1-2 (November 1996): 19–30. http://dx.doi.org/10.1016/s0022-510x(96)00148-7.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

40

Pinn, M. E., D. G. Gold, I. A. Petersen, T. G. Osborn, P. D. Brown, and R. C. Miller. "Radiotherapy and Systemic Lupus Erythematosus: The Mayo Clinic Experience." International Journal of Radiation Oncology*Biology*Physics 69, no. 3 (November 2007): S544—S545. http://dx.doi.org/10.1016/j.ijrobp.2007.07.1793.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

41

Wong, Priscilla H., Karla E. Adams, Geoffrey S. Carlson, and James M. Quinn. "Experience with Epinephrine Delivery in Immunotherapy-Associated Systemic Reactions." Journal of Allergy and Clinical Immunology 135, no. 2 (February 2015): AB214. http://dx.doi.org/10.1016/j.jaci.2014.12.1636.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

42

Cabellos, C., J. M. Nolla, R. Verdaguer, I. Pelegrin, A. Ribera, J. Ariza, and P. F. Viladrich. "Arthritis related to systemic meningococcal disease: 34 years’ experience." European Journal of Clinical Microbiology & Infectious Diseases 31, no. 10 (April 3, 2012): 2661–66. http://dx.doi.org/10.1007/s10096-012-1610-1.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

43

Pauling, John D., Lesley Ann Saketkoo, Marco Matucci-Cerinic, Francesca Ingegnoli, and Dinesh Khanna. "The patient experience of Raynaud’s phenomenon in systemic sclerosis." Rheumatology 58, no. 1 (March 12, 2018): 18–26. http://dx.doi.org/10.1093/rheumatology/key026.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

44

Bajracharya, Luna, and Surya Bahadur Thapa. "Childhood Systemic Lupus Erythematosus: A Tertiary Care Centre Experience." Journal of Nepal Paediatric Society 35, no. 2 (January 20, 2016): 111–16. http://dx.doi.org/10.3126/jnps.v35i2.13282.

Повний текст джерела

Анотація:

Introduction: Systemic lupus erythematosus (SLE) is a chronic immunologic disorder with multisystem manifestations. Even more awareness is required to diagnose the disease at younger age. Objective of this study was to explore clinico-laboratory manifestations and management of SLE in children at Tribhuvan University Teaching Hospital (TUTH).Materials and Methods: The study was retrospective hospital based study conducted from 15th July, 2008 to 14th July, 2014. Medical charts of all children and adolescent (6- 16years of age) with SLE admitted at TUTH were reviewed for analysis of data.Results: The total number of patients was 33, with 28(84.8%) girls and 5 (15.2%) boys. The mean age of diagnosis was 12.12 (SD 1.89). Facial puffiness (27.3%) and arthralgia (24.2%) were the commonest presentations at disease onset. The most frequent clinical features during the entire course of illness were edema (78.9%), anemia (69.7%) and fever (66.7%). Twenty three (69.6%) patients underwent renal biopsy in which class IV was the commonest lupus nephritis. The commonly used drugs after prednisolone were intravenous cyclophosphamide, intravenouse methylprednisolone and mycophenolate mofetil. Total 17 (51.5%) patients went into remission. Two patients died due to active lupus and four due to sepsis.Conclusion: Lupus nephritis was the commonest feature at disease onset, at the time of diagnosis and throughout the disease course among Nepalese children with SLE. The most frequently used medications were prednisolone and iv cyclophosphamide. Infection and active lupus were the leading causes of complications and death.J Nepal Paediatr Soc 2015;35(2):111-116

Стилі APA, Harvard, Vancouver, ISO та ін.

45

Ul Azim, MuhammedArshad, Abdus Salam, and SkNishat Abdullah. "Experience of systemic lupus erythematosus in South-Western Bangladesh." Saudi Journal of Kidney Diseases and Transplantation 30, no. 3 (2019): 743. http://dx.doi.org/10.4103/1319-2442.261365.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

46

Aseeva, E. A., S. K. Soloviev, A. A. Mesnyankina, M. E. Tsanyan, and E. L. Nasonov. "EXPERIENCE WITH BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS." Rheumatology Science and Practice 53, no. 3 (September 10, 2015): 329. http://dx.doi.org/10.14412/1995-4484-2015-329-335.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

47

Wong, Priscilla H., Karla E. Adams, Geoffrey S. Carlson, and James M. Quinn. "Experience with epinephrine delivery in immunotherapy-associated systemic reactions." Annals of Allergy, Asthma & Immunology 116, no. 2 (February 2016): 166–68. http://dx.doi.org/10.1016/j.anai.2015.11.009.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

48

Tselios, Konstantinos, Kristy Su-Ying Yap, Rattapol Pakchotanon, Ari Polachek, Jiandong Su, Murray B. Urowitz, and Dafna D. Gladman. "Psoriasis in systemic lupus erythematosus: a single-center experience." Clinical Rheumatology 36, no. 4 (February 6, 2017): 879–84. http://dx.doi.org/10.1007/s10067-017-3566-0.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

49

Almagro Torres, F., A. Baena Cubero, G. Garcia Fernandez, M. J. Martinez Quesada, J. A. Lopez Lopez, and M. S. Duran Nieto. "Primary Systemic Amyloidosis Associated With Multiple Myeloma. Our Experience." Clinical Lymphoma Myeloma and Leukemia 15 (September 2015): e206. http://dx.doi.org/10.1016/j.clml.2015.07.449.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

50

Bawden, Richard. "Systemic development at Hawkesbury: some personal lessons from experience." Systems Research and Behavioral Science 22, no. 2 (March 30, 2005): 151–64. http://dx.doi.org/10.1002/sres.682.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!